Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ADXS Ayala Pharmaceuticals	$0.05	$0.07	$0.02 ▼ $0.78	$2.26M	1.17	4,709 shs	18 shs
CANF Can-Fite BioPharma	$0.66 -0.8%	$0.89	$0.63 ▼ $3.12	$2.34M	1.02	209,631 shs	91,392 shs
NBY NovaBay Pharmaceuticals	$0.91 -14.9%	$0.64	$0.44 ▼ $1.25	$5.30M	0.4	1.31 million shs	1.67 million shs
NEPT Neptune Wellness Solutions		$0.39	$0.19 ▼ $28.00	$906K	2.19	462,687 shs	2.25 million shs

Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ADXS Ayala Pharmaceuticals	0.00%	-1.12%	+59.16%	+51.86%	+158.54%
CANF Can-Fite BioPharma	-0.75%	0.00%	-36.14%	-36.38%	-70.88%
NBY NovaBay Pharmaceuticals	-14.94%	+47.38%	+38.84%	+59.75%	+68.23%
NEPT Neptune Wellness Solutions	0.00%	0.00%	0.00%	0.00%	0.00%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ADXS Ayala Pharmaceuticals	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
CANF Can-Fite BioPharma	1.789 of 5 stars	3.5	2.0	0.0	0.0	0.6	0.0	1.3
NBY NovaBay Pharmaceuticals	0.3657 of 5 stars	1.5	0.0	0.0	0.0	0.6	0.0	1.3
NEPT Neptune Wellness Solutions	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ADXS Ayala Pharmaceuticals	0.00	N/A	N/A	N/A
CANF Can-Fite BioPharma	3.00	Buy	$14.00	2,018.00% Upside
NBY NovaBay Pharmaceuticals	3.00	Buy	$0.85	-6.60% Downside
NEPT Neptune Wellness Solutions	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Latest NEPT, NBY, ADXS, and CANF Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
7/29/2025	CANF Can-Fite BioPharma	D. Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$10.00

(Data available from 8/23/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ADXS Ayala Pharmaceuticals	$3.24M	0.70	N/A	N/A	($2.06) per share	-0.03
CANF Can-Fite BioPharma	$674K	3.47	N/A	N/A	$1.76 per share	0.38
NBY NovaBay Pharmaceuticals	$9.78M	0.54	N/A	N/A	$4.25 per share	0.21
NEPT Neptune Wellness Solutions	$52.62M	0.00	N/A	N/A	($91.90) per share	0.00

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ADXS Ayala Pharmaceuticals	-$48.07M	-$7.98	N/A	∞	N/A	N/A	N/A	N/A	N/A
CANF Can-Fite BioPharma	-$7.63M	-$1.79	N/A	N/A	N/A	N/A	N/A	N/A	N/A
NBY NovaBay Pharmaceuticals	-$9.64M	-$53.72	N/A	N/A	N/A	-102.72%	-7,293.78%	-158.41%	N/A
NEPT Neptune Wellness Solutions	-$60.46M	-$106.72	N/A	N/A	N/A	-128.13%	N/A	-141.94%	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ADXS Ayala Pharmaceuticals	N/A	N/A	N/A	N/A	N/A
CANF Can-Fite BioPharma	N/A	N/A	N/A	N/A	N/A
NBY NovaBay Pharmaceuticals	N/A	N/A	N/A	N/A	N/A
NEPT Neptune Wellness Solutions	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ADXS Ayala Pharmaceuticals	N/A	N/A	N/A
CANF Can-Fite BioPharma	N/A	2.93	N/A
NBY NovaBay Pharmaceuticals	N/A	1.15	0.91
NEPT Neptune Wellness Solutions	N/A	0.23	0.10

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ADXS Ayala Pharmaceuticals	7.18%
CANF Can-Fite BioPharma	21.00%
NBY NovaBay Pharmaceuticals	23.25%
NEPT Neptune Wellness Solutions	14.44%

Insider Ownership

Company	Insider Ownership
ADXS Ayala Pharmaceuticals	0.63%
CANF Can-Fite BioPharma	0.80%
NBY NovaBay Pharmaceuticals	0.10%
NEPT Neptune Wellness Solutions	5.10%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ADXS Ayala Pharmaceuticals	20	42.63 million	42.36 million	Not Optionable
CANF Can-Fite BioPharma	8	3.54 million	N/A	Not Optionable
NBY NovaBay Pharmaceuticals	30	5.82 million	4.88 million	Not Optionable
NEPT Neptune Wellness Solutions	58	4.53 million	4.30 million	Not Optionable

NEPT, NBY, ADXS, and CANF Headlines

Recent News About These Companies

t20 world cup 2020 teams

December 28, 2024 | bweducation.businessworld.inB

Neptune Wellness Solutions Inc. (NEPTF)

November 27, 2024 | finance.yahoo.com

Three Breakthrough Strategies To Revolutionize Pain Relief And Wellness

November 7, 2024 | forbes.com

The Aesthetic Experience introduces AE Wellness

November 7, 2024 | koin.comK

Neptune homeless camp down to 13 people as deadline to shut it down is nearly here

October 18, 2024 | app.comA

The Next Era of Lenovo Neptune Water Cooling Arrives to Efficiently Power NVIDIA Blackwell Platform and AI at Every Scale

October 15, 2024 | valdostadailytimes.comV

Open Letter to Dominican President Luis Abinader: Stop Deportations Now!

October 12, 2024 | counterpunch.orgC

2024 Wellness Olympia Results & Prize Money — Isabelle Nunes Wins 1st Title

October 12, 2024 | fitnessvolt.comF

Kroger Wellness Festival canceled, products will go to people impacted by Helene

September 28, 2024 | local12.comL

Restore Hyper Wellness and MECOTEC Announce Strategic Partnership in Cryotherapy Solutions

September 24, 2024 | tmcnet.com

Capitol Wellness Solutions opens new medical marijuana dispensary in Baton Rouge

September 21, 2024 | yahoo.com

Capitol Wellness Solutions opened a new medical marijuana dispensary, for the first time in Louisiana

September 21, 2024 | msn.com

Giant space balloon ‘Spaceship Neptune-Excelsior’ completes 2nd test flight in Titusville

September 19, 2024 | clickorlando.comC

Space Perspective's Spaceship Neptune capsule lifts off from ship on test flight

September 16, 2024 | floridatoday.comF

Neptune Beach, FL Weather Conditions

August 30, 2024 | wunderground.comW

High-tech wizardry and old-fashioned care will grow pot indoors at Neptune's Garden

August 30, 2024 | app.comA

Your Daily Horoscope: Sunday, August 25, 2024

August 25, 2024 | msn.com

Exploring Alternative Wellness Options for Stress Management & Relaxation

August 25, 2024 | spacecoastdaily.comS

Sunrise Total Mind Wellness closing its doors in New Braunfels

August 18, 2024 | herald-zeitung.comH

Neptune Medical raises $97M for surgical robotics, spins out Jupiter Endovascular

August 16, 2024 | therobotreport.comT

New MarketBeat Followers Over Time

NEPT, NBY, ADXS, and CANF Company Descriptions

Ayala Pharmaceuticals NASDAQ:ADXS

$0.05 0.00 (0.00%)

As of 08/22/2025

Ayala Pharmaceuticals, Inc., a clinical-stage oncology company, primarily focuses on developing and commercializing small molecule therapeutics for people living with rare tumors and aggressive cancers. The company's lead candidates under development include AL102, an oral gamma secretase inhibitor for desmoid tumors; and aspacytarabine (BST-236), a novel proprietary anti-metabolite for first line treatment in unfit acute myeloid leukemia. Ayala Pharmaceuticals, Inc. is based in Wilmington, Delaware.

Can-Fite BioPharma NYSE:CANF

$0.66 -0.01 (-0.75%)

Closing price 08/22/2025 04:00 PM Eastern

Extended Trading

$0.66 0.00 (-0.15%)

As of 08/22/2025 07:23 PM Eastern

Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of cancer, liver inflammatory diseases, and erectile dysfunction. The company's lead drug candidate Piclidenoson, which has been completed Phase III clinical trial for the treatment of psoriasis; and Phase II clinical trial for the treatment of COVID-19. It also develops Namodenoson that is in Phase III clinical trial for the treatment of hepatocellular carcinoma, as well as in Phase IIb trial for the treatment of non-alcoholic steatohepatitis; and CF602, which is in pre-clinical trial for the treatment of erectile dysfunction. In addition, the company develops commercial predictive biomarker blood test kit for A3AR. Can-Fite BioPharma Ltd. has license and collaboration agreement with CMS Medical to develop, manufacture, and commercialize Piclidenoson and Namodenoson; and collaboration agreement with Univo Pharmaceuticals to identify and co-develop specific formulations of cannabis components for the treatment of cancer, inflammatory, autoimmune, and metabolic diseases. The company was formerly known as Can-Fite Technologies Ltd. and changed its name to Can-Fite BioPharma Ltd. in January 2001. Can-Fite BioPharma Ltd. was incorporated in 1994 and is headquartered in Petah Tikva, Israel.

NovaBay Pharmaceuticals NYSE:NBY

$0.91 -0.16 (-14.94%)

As of 08/22/2025 04:00 PM Eastern

NovaBay Pharmaceuticals, Inc., a biopharmaceutical company, develops and sells eyecare, skincare, and wound care products in the United States and internationally. It offers Avenova Spray, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products, which are used for cleansing and irrigation as part of surgical procedures, as well as treating certain wounds, burns, ulcers, and other injuries under the NeutroPhase and PhaseOne brands. The company also provides dermatological solutions to address skincare concerns comprising keratosis pilaris, rosacea and eczema, anti-aging, hyperhidrosis, excessive hair, and acne under the DERMAdoctor brand. It sells its products through traditional and digital beauty retailers and distributors, as well as online. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.

Neptune Wellness Solutions NASDAQ:NEPT

Neptune Wellness Solutions Inc., a health and wellness products company, specializes in the extraction, purification and formulation of cannabis products, as well as other specialty ingredients, such as MaxSimil, a patented ingredient that enhances the absorption of lipid-based nutraceuticals, and various other marine and seed oils. Its custom formulations are available in various delivery forms, such as softgels, liquid solutions, nutritional emulsions, and chewables. Neptune Wellness Solutions Inc. was founded in 1998 and is headquartered in Laval, Canada.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time